Dabrafenib Mesylate
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1195768-06-9
Chemical name
Dabrafenib Mesylate
Molecular formula
C24H24F3N5O5S3
Molecular weight
615.7 g/mol
Synonyms
Taflinar; GSK 2118436B; Dabrafenib methanesulfonate; dabrafenib monomesylate; GSK-2118436B MESYLATE; GSK2118436 Methane sulfonate salt; GSK2118436B, methane sulfonate salt; GSK-2118436 METHANESULFONATE SALT; Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); GSK-2118436B METHANESULFONATE SALT; BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1); N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate
InChIKey
YKGMKSIHIVVYKY-UHFFFAOYSA-N
PubChem CID
44516822
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302, H315, H319, H335
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.